Home Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism
Article
Licensed
Unlicensed Requires Authentication

Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism

  • Jian-Ping Cheng , Hong-Ni Yue , Shao-Gang Ma EMAIL logo , Yue Jin , Wei Xu and Feng Bai
Published/Copyright: July 6, 2013
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 26 Issue 11-12

Abstract

Aim: To investigate the influence of overt hyperthyroidism and euthyroid congenital hypothyroidism on fasting glucagon-like peptide-1 (GLP-1) levels.

Methods: A total of 30 untreated overt hyperthyroidism patients, 17 euthyroid congenital hypothyroidism children, and age- and sex-matched controls were enrolled. Levels of GLP-1, insulin, glucose, and homeostasis model assessment (HOMA-IR) were measured and evaluated.

Results: Fasting GLP-1, blood glucose, insulin, and HOMR-IR levels were higher in patients with overt hyperthyroidism than in controls (p=0.030, p=0.008, p=0.004, p=0.037, respectively). These parameters in euthyroid hypothyroidism were similar to the controls. In euthyroid congenital hypothyroidism and overt hyperthyroidism patients, serum GLP-1 levels were not correlated with thyroid hormone, blood glucose, insulin, and HOMR-IR.

Conclusions: Fasting GLP-1 levels in the peripheral circulation were significantly increased in overt hyperthyroidism, however, they were no different in euthyroid congenital hypothyroidism.

Keywords: congenital hypothyroidism; glucagon-like peptide-1; hyperthyroidism
Corresponding author: Shao-Gang Ma, Department of Endocrinology and Metabolism, Huai’an Hospital Affiliated to Xuzhou Medical College and Huai’an Second People’s Hospital, 62 Huaihai Road South, Huai’an Jiangsu 223002, China, Phone: +86-773-2813777, Fax: +86-773-2813777, E-mail:

References

1. Kieffer JT, Habener FJ. The glucagon-like peptides. Endocr Rev 1999;20:876–913.10.1210/edrv.20.6.0385Search in Google Scholar PubMed

2. Heo KS, Fujiwara K, Abe J. Glucagon-like peptide-1 and its cardiovascular effects. Curr Atheroscler Rep 2012;14:422–8.10.1007/s11883-012-0265-9Search in Google Scholar PubMed

3. Yerram P, Whaley-Connell A. Novel role for the incretins in blood pressure regulation. Curr Opin Nephrol Hypertens 2012;21:463–8.10.1097/MNH.0b013e328356bccdSearch in Google Scholar PubMed

4. Hölscher C. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs 2012;26:871–82.10.2165/11635890-000000000-00000Search in Google Scholar PubMed

5. Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009;160: 785–90.10.1530/EJE-08-0797Search in Google Scholar PubMed

6. Maratou E, Hadjidakis DJ, Peppa M, Alevizaki M, Tsegka K, et al. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol 2010;163: 625–30.10.1530/EJE-10-0246Search in Google Scholar PubMed

7. Sawicka B, Bossowski A, Szalecki M, Wysoka J, Koput A, et al. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases. J Pediatr Endocrinol Metab 2010;23:345–54.10.1515/jpem.2010.055Search in Google Scholar PubMed

8. Alioğlu B, Kılıç N, Şimşek E, Dallar Y. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism. J Clin Res Pediatr Endocrinol 2012;4: 146–50.10.4274/Jcrpe.652Search in Google Scholar PubMed PubMed Central

9. Ma SG, Fang PH, Hong B, Yu WN. The R450H mutation and D727E polymorphism of the thyrotropin receptor gene in a Chinese child with congenital hypothyroidism. J Pediatr Endocrinol Metab 2010;23:1339–44.Search in Google Scholar

10. Ma SG, Wu XJ, Liu H, Xu W, He L. Mutations of the thyroid peroxidase gene in Chinese siblings with congenital goitrous hypothyroidism. Arq Bras Endocrinol Metabol 2012;56:614–7.10.1590/S0004-27302012000900003Search in Google Scholar PubMed

11. Jung H, Hong Y, Lee D, Pang K, Kim Y. The association between some endocrine disruptors in human plasma and the occurrence of congenital hypothyroidism. Environ Toxicol Pharmacol 2013;35:278–83.10.1016/j.etap.2013.01.002Search in Google Scholar PubMed

12. Farahani H, Ghasemi A, Roghani M, Zahediasl S. Effect of neonatal hypothyroidism on carbohydrate metabolism, insulin secretion, and pancreatic islets morphology of adult male offspring in rats. J Endocrinol Invest 2013;36:44–9.Search in Google Scholar

13. DeLeon MJ, Chandurkar V, Albert SG, Mooradian AD. Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects. Diabetes Res Clin Pract 2002;56:101–6.10.1016/S0168-8227(01)00359-XSearch in Google Scholar

14. Zhang F, Tang X, Cao H, Lü Q, Li N, et al. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance. Int J Med Sci 2012;9:574–81.10.7150/ijms.4128Search in Google Scholar PubMed PubMed Central

15. Vaidyanathan P, Pathak M, Kaplowitz PB. In congenital hypothyroidism, an initial L-thyroxine dose of 10-12 μg/kg/day is sufficient and sometimes excessive based on thyroid tests 1 month later. J Pediatr Endocrinol Metab 2012;25:849–52.10.1515/jpem-2012-0025Search in Google Scholar PubMed

16. Tatsch E, Bochi GV, Piva SJ, Pereira RS, Kober H, et al. Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose. Clin Lab 2012;58:347–50.Search in Google Scholar

17. Yu Y, Ouyang XJ, Lou QL, Gu LB, Mo YZ, et al. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects. Korean J Intern Med 2012;27: 41–6.10.3904/kjim.2012.27.1.41Search in Google Scholar PubMed PubMed Central

18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Search in Google Scholar PubMed

19. Siemińska L, Foltyn W, Głogowska-Szeląg J, Kajdaniuk D, Marek B, et al. Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves’ disease women. Endokrynol Pol 2013;64:26–9.Search in Google Scholar

20. Svendsen PF, Nilas L, Madsbad S, Holst JJ. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. Metabolism 2009;58:586–93.10.1016/j.metabol.2008.11.009Search in Google Scholar PubMed

21. Vrbikova J, Hill M, Bendlova B, Grimmichova T, Dvorakova K, et al. Incretin levels in polycystic ovary syndrome. Eur J Endocrinol 2008;159:121–7.10.1530/EJE-08-0097Search in Google Scholar PubMed

22. Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia 2013;56:965–72.10.1007/s00125-013-2841-0Search in Google Scholar PubMed PubMed Central

23. Handisurya A, Pacini G, Tura A, Gessl A, Kautzky-Willer A. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) 2008;69:963–9.10.1111/j.1365-2265.2008.03280.xSearch in Google Scholar PubMed

24. Kubicky RA, Weiner E, Carlson B, De Luca F. Effect of prolonged discontinuation of L-thyroxine replacement in a child with congenital hypothyroidism. Case Rep Endocrinol 2012;2012:841947.10.1155/2012/841947Search in Google Scholar PubMed PubMed Central

25. Maitusong R, Japaer R, Zhao ZY, Yang RL, Huang XL, et al. Newborn screening in Zhejiang, China. Chin Med J (Engl) 2012;125:702–4.Search in Google Scholar

26. Gheissari A, Hashemipour M, Khosravi P, Adibi A. Different aspects of kidney function in well-controlled congenital hypothyroidism. J Clin Res Pediatr Endocrinol 2012;4: 193–8.10.4274/Jcrpe.811Search in Google Scholar

27. Akin MA, Aydogan S, Gunes T, Artis AS, Karakukcu M, et al. Changes of red blood cell rheology in newborns with congenital hypothyroidism during treatment. J Matern Fetal Neonatal Med 2013; doi:10.3109/14767058.2013.791270.10.3109/14767058.2013.791270Search in Google Scholar PubMed

Received: 2013-4-4
Accepted: 2013-5-16
Published Online: 2013-07-06
Published in Print: 2013-11-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Application of imaging modalities for evaluating neuroblastoma
  5. Images in pediatric endocrinology
  6. Lingual thyroid
  7. Original articles
  8. A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism
  9. Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism
  10. Perinatal complications and higher risks of offspring thyroid dysfunction in early childhood of Graves’ disease mothers with euthyroidism
  11. Clinical characteristics and management of cranial diabetes insipidus in infants
  12. Desmopressin administration in children with central diabetes insipidus: a retrospective review
  13. An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland
  14. Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted
  15. Vitamin D status is associated with early markers of cardiovascular disease in prepubertal children
  16. Evaluation of bone mineral density in children with type 1 diabetes mellitus
  17. Observational study of diabetes management in type 1 diabetic school-age children during holiday versus school days
  18. Relationship of body mass index and GAD65 antibody status on β-cell secretion at diabetes onset in African-American children
  19. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus
  20. Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease
  21. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey
  22. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes
  23. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR)
  24. Prevalence of metabolic syndrome in obese Chilean children and association with gene variants of the leptin-melanocortin system
  25. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents
  26. Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?
  27. Patient reports
  28. Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn
  29. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism
  30. A novel atypical presentation of insulin autoimmune syndrome (Hirata’s disease) in a child
  31. Diagnosis of septo-optic dysplasia in a neonate with hypernatremia, hypoglycemia, and persistent hypothermia
  32. Speech and language delay in two children: an unusual presentation of hyperthyroidism
  33. Lissencephaly presenting with congenital hypothyroidism
  34. PHEX gene mutation in a Chinese family with six cases of X-linked hypophosphatemic rickets
  35. Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood
  36. A family with Camurati-Engelman disease: the role of the missense p.R218C mutation in TGFbeta1 in bones and endocrine glands
  37. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
  38. Central precocious puberty in a girl with Prader-Willi syndrome
  39. Type 1 diabetes mellitus in a patient with homozygous sickle cell anemia
  40. Short communication
  41. No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children
  42. Letter to the Editor
  43. Reliability and validity of homeostasis model assessment for insulin resistance and β-cell dysfunction in critically ill children with hyperglycemia
https://doi.org/10.1515/jpem-2013-0135
Keywords for this article
congenital hypothyroidism; glucagon-like peptide-1; hyperthyroidism

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Application of imaging modalities for evaluating neuroblastoma
  5. Images in pediatric endocrinology
  6. Lingual thyroid
  7. Original articles
  8. A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism
  9. Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism
  10. Perinatal complications and higher risks of offspring thyroid dysfunction in early childhood of Graves’ disease mothers with euthyroidism
  11. Clinical characteristics and management of cranial diabetes insipidus in infants
  12. Desmopressin administration in children with central diabetes insipidus: a retrospective review
  13. An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland
  14. Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted
  15. Vitamin D status is associated with early markers of cardiovascular disease in prepubertal children
  16. Evaluation of bone mineral density in children with type 1 diabetes mellitus
  17. Observational study of diabetes management in type 1 diabetic school-age children during holiday versus school days
  18. Relationship of body mass index and GAD65 antibody status on β-cell secretion at diabetes onset in African-American children
  19. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus
  20. Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease
  21. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey
  22. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes
  23. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR)
  24. Prevalence of metabolic syndrome in obese Chilean children and association with gene variants of the leptin-melanocortin system
  25. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents
  26. Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?
  27. Patient reports
  28. Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn
  29. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism
  30. A novel atypical presentation of insulin autoimmune syndrome (Hirata’s disease) in a child
  31. Diagnosis of septo-optic dysplasia in a neonate with hypernatremia, hypoglycemia, and persistent hypothermia
  32. Speech and language delay in two children: an unusual presentation of hyperthyroidism
  33. Lissencephaly presenting with congenital hypothyroidism
  34. PHEX gene mutation in a Chinese family with six cases of X-linked hypophosphatemic rickets
  35. Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood
  36. A family with Camurati-Engelman disease: the role of the missense p.R218C mutation in TGFbeta1 in bones and endocrine glands
  37. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
  38. Central precocious puberty in a girl with Prader-Willi syndrome
  39. Type 1 diabetes mellitus in a patient with homozygous sickle cell anemia
  40. Short communication
  41. No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children
  42. Letter to the Editor
  43. Reliability and validity of homeostasis model assessment for insulin resistance and β-cell dysfunction in critically ill children with hyperglycemia
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 27.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0135/html
Scroll to top button